Dirk Kasel
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
- Oncology 3
- Cancer Treatment and Pharmacology 1
- Co-authors
- Horst Beier (2 shared papers)Hartmut Grasemann (1 shared paper)Silvana van Koningsbruggen (1 shared paper)Félix Ratjen (1 shared paper)E. Rietschel (1 shared paper)Uwe Fuhr (6 shared papers)Alexander Jetter (4 shared papers)Wilhelm Gebhardt (1 shared paper)
- Journals
- European Journal of Clinical Pharmacology (2 papers)Rapid Communications in Mass Spectrometry (2 papers)Pharmaceutical Research (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)Clinical Pharmacokinetics (1 paper)
- Partner nations
- GermanySwitzerlandSpain
In The Last Decade
Dirk Kasel
8 papers receiving 320 citations
Peers
Comparison fields: 5 of 70
- Molecular Medicine 120
- Pharmacology 81
- Critical Care and Intensive Care Medicine 28
- Pharmacology 85
- Occupational Therapy 16
Countries citing papers authored by Dirk Kasel
This map shows the geographic impact of Dirk Kasel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Kasel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Kasel more than expected).
Fields of papers citing papers by Dirk Kasel
This network shows the impact of papers produced by Dirk Kasel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Kasel. The network helps show where Dirk Kasel may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Kasel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 166 | |
| 2 | 2004 | 52 | |
| 3 | 2001 | 38 | |
| 4 | 2004 | 31 | |
| 5 | 2007 | 16 | |
| 6 | 2007 | 11 | |
| 7 | 2004 | 9 | |
| 8 | 2007 | 7 |
About Dirk Kasel
Dirk Kasel is a scholar working on Pharmacology, Oncology, Molecular Biology, Small Animals and Occupational Therapy, having authored 8 papers that have together received 330 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Cancer therapeutics and mechanisms (2 papers), Cancer Treatment and Pharmacology (1 paper), Cystic Fibrosis Research Advances (1 paper), Pain Mechanisms and Treatments (1 paper), Chemical Reactions and Isotopes (1 paper), Veterinary Pharmacology and Anesthesia (1 paper) and Analytical Chemistry and Chromatography (1 paper). The work is most often cited by research in Molecular Medicine (120 citations), Pharmacology (81 citations), Critical Care and Intensive Care Medicine (28 citations), Pharmacology (85 citations) and Occupational Therapy (16 citations). Dirk Kasel has collaborated with scholars based in Germany, Switzerland and Spain. Frequent co-authors include Horst Beier, Hartmut Grasemann, Silvana van Koningsbruggen, Félix Ratjen, E. Rietschel, Uwe Fuhr, Alexander Jetter, Wilhelm Gebhardt, M Zaigler and K. T. E. Beckurts. Their work appears in journals such as European Journal of Clinical Pharmacology, Rapid Communications in Mass Spectrometry, Pharmaceutical Research, Journal of Antimicrobial Chemotherapy and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.